skin rejuvenation
Optimised PN concentrations across the VITARAN range
Proprietary purification process for consistent high purity
CE-marked professional polynucleotide injectables
Developed for professional protocols to support skin quality restoration
What Is VITARAN?
VITARAN is a CE-marked polynucleotide injectable developed for professional use in aesthetic medicine.
Formulated from highly purified salmon trout DNA fragments, it is designed to support cellular repair mechanisms and improve overall skin quality.
VITARAN polynucleotides contribute to tissue regeneration, enhancement of skin barrier function, and long-term dermal restoration when used within appropriate clinical protocols.
The Power Of Polynucleotides
VITARAN S (20 mg/ml PN) – Refined polynucleotide formulation designed for delicate and precision treatment areas, supporting subtle skin quality enhancement.
VITARAN i (20 mg/ml PN) – Periorbital formulation developed specifically for the eye area, supporting hydration, biorestructuring, and improved skin quality.
VITARAN (20 mg/ml PN) – Core formulation for face, neck, and décolletage protocols, supporting deep skin renewal, elasticity, and overall skin revitalisation.
Together, these three formulations represent the complete HP VITARAN professional polynucleotide portfolio, developed exclusively for qualified aesthetic practice.
Clinically Supported Regenerative Outcomes
The VITARAN range is developed to support measurable improvements in skin quality through regenerative mechanisms at the cellular level.
Used within appropriate medical protocols, VITARAN polynucleotides assist in improving hydration, elasticity, and dermal structure over time.
The Science Behind VITARAN Polynucleotides
VITARAN polynucleotides are designed to act at a cellular level, supporting tissue repair processes and extracellular matrix integrity.
By promoting regenerative activity within the dermis, VITARAN contributes to structural skin improvement and long-term dermal health.
Explore the scientific rationale and clinical framework behind VITARAN polynucleotide treatments.